Covid Vaccine for children: The entire world is gearing up to fight against Covid 19 by trying to get all its citizens vaccinated. India with its large population has started its vaccination drive and there is still a long way to go. With the manufacturing of Covaxin and Covishield and the import of Sputnik, India’s target is to get all its citizens vaccinated by the end of the year, 2021.
The vaccination for citizens above 18 years has already started and nearly 4% of the population has been fully vaccinated. The vaccine for children below 18 years was uncertain, and many trials were being conducted. Covaxin recently started its trials on children and the research of the vaccine’s effectiveness on children is still in process.
Now, another type of vaccine is being manufactured in Ahmadabad, Gujarat for the age groups between 12 to 18.
Zydus Cadila (ZyCov-D), is a Covid vaccine being produced by an Ahmadabad based company with the support from Centre’s National Bio pharma Mission, and is likely to apply for licensure of the vaccine in the next two weeks, as per the statement of a Senior Government Official.
VK Paul, a NITI Aayog member on Friday, said that not only Covaxin but also Zydus is being tested on children. He also said that the Covaxin trials might not take long as they are immunogenic trials and hopefully, there would be enough data in the coming two weeks about Zydus which might give an assurance that it might be given to children.
He also made it clear that a proper strategy is required, so that there will be no shortage of doses and all the children will be vaccinated duly once there is a proper confirmation on the efficiency of the vaccines.
The vaccine ZyCov-D was found to be safe and immunogenic in the first two phases of trials. Reports suggest that, plans to start the trials in children between the age groups of 5 to 12 after covering the adults and the children from 12 to 18 age groups, are being made. If everything goes well, the vaccine will be potentially approved for use in children aged 12 to 18 years.
Meanwhile, Pfizer is also under consideration for administration in children. Covaxin is also conducting its trials regularly, and the official approval for use in children is yet to be received. Bharat Biotech along with WHO is trying its best to achieve the milestone of providing vaccine to all the citizens including the children of the country.
If these vaccines are approved, it would be a huge achievement for India, as the major vaccine production is taking place in India, and it would also help the citizens to fight the pandemic more effectively.